Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01054716 · ClinicalTrials.gov registry record
Evaluation of a Noninvasive Fetal RHD Genotyping Test
A clinical trial, sponsored by Sequenom.
- Completed
- Registry status
- 500
- Enrollment target
NCT01054716: Completed study, sponsored by Sequenom.
NCT01054716 is a clinical trial that has completed, run by Sequenom. The registered enrollment target is 500 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01054716 has completed, sponsored by Sequenom.
- COMPLETED
- Registry status
- 500 participants
- Enrollment target
Study Summary
This study will collect whole blood samples from pregnant subjects who are RhD negative by serology to develop an assay for RHD determination of the fetus.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2009-05 |
| Est. Completion | 2010-11 |
What the finished NCT01054716 record still lists
NCT01054716 is an observational study that tracks outcomes without assigning an intervention. The registered 500 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT01054716 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01054716 about?
NCT01054716 is a clinical study titled "Evaluation of a Noninvasive Fetal RHD Genotyping Test". This study will collect whole blood samples from pregnant subjects who are RhD negative by serology to develop an assay for RHD determination of the fetus.
What is the current status of trial NCT01054716?
This trial is currently completed. The enrollment target is 500 participants. The study started on 2009-05. Estimated completion is 2010-11.
Who is sponsoring clinical trial NCT01054716?
This trial is sponsored by Sequenom, which has 26 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001230 · 500 participants
Host Response to Infection and Treatment in Filarial Diseases
- NCT00001529 · 500 participants
Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives
- NCT00697411 · 500 participants
Study of Selected X-Linked Disorders: Aicardi Syndrome
- NCT00903110 · 500 participants
Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia